Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?

BACKGROUND: Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease worldwide. Renin-angiotensin system (RAS) inhibitors are the first-line treatment for diabetic patients with hypertension. However, whether RAS inhibitors prevent the development of DKD remains controversial. W...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Pharmacol Toxicol
Главные авторы: Miyazaki, Hiroki, Babazono, Akira, Nishi, Takumi, Maeda, Toshiki, Imatoh, Takuya, Ichiba, Masayoshi, Une, Hiroshi
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2015
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4567802/
https://ncbi.nlm.nih.gov/pubmed/26362195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-015-0024-y
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы